Contribution: Canadian International Innovation Program
iProgen Biotech Inc.
$600,000.00
CIIP Korea Project NextGenADC
FY 2019-20 · 2019-11-01
Summary
CIIP Korea project NextGenADC will integrate the protein engineering expertise and enhanced antibody delivery technology of iProgen Biotech Inc. (Canada) with the unique linker-payload and site-specific conjugation technologies of AbTis Co., Ltd. (Korea). Together, this international partnership aims to create a next generation antibody-drug conjugate (ADC) as a potential therapeutic agent with a superior efficacy and safety profile for treating patients with solid tumours.
Department
Program
Canadian International Innovation Program
Recipient
Location
Burnaby|Burnaby, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
826908816
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2019-11-01 | 2019-20 | $600,000.00 |
| 1 | 2019-11-01 | 2019-20 | $600,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 61 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 61 jours.
Agreement End Date
2021-12-31
Agreement Number
939055
Agreement Start Date
2019-11-01
Agreement Title
CIIP Korea Project NextGenADC
Agreement Title (French)
Projet NextGenADC du PCII en Corée
Agreement Type
Contribution
Agreement Value
$600,000.00
Amendment Date
2021-03-12
Amendment Number
1
Coverage
The Canadian International Innovation Program supports industrial R & D partnerships and matchmaking activities between Canadian companies and foreign partners with a view to accelerating commercialization and facilitating market access. | Le Programme canadien de l’innovation à l’international vise à appuyer les partenariats de recherche et développement industriels et les activités de jumelage entre les entreprises canadiennes et les partenaires étrangers, en vue d'accélérer la commercialisation et de faciliter l'accès aux marchés.
Description
CIIP Korea project NextGenADC will integrate the protein engineering expertise and enhanced antibody delivery technology of iProgen Biotech Inc. (Canada) with the unique linker-payload and site-specific conjugation technologies of AbTis Co., Ltd. (Korea). Together, this international partnership aims to create a next generation antibody-drug conjugate (ADC) as a potential therapeutic agent with a superior efficacy and safety profile for treating patients with solid tumours.
Description (French)
Le projet NextGenADC du PCII en Corée intégrera l'expertise en ingénierie des protéines et la technologie améliorée de libération d'anticorps d'iProgen Biotech Inc. (Canada) avec la charge utile de liaison unique et les technologies de conjugaison propres à AbTis Co., Ltd. (Corée). Ensemble, ce partenariat international vise à créer une nouvelle génération de conjugué anticorps-médicament (ADC) comme agent thérapeutique potentiel avec une efficacité et un profil de sécurité supérieurs pour traiter les patients présentant des tumeurs solides.
Expected Results
The Canadian International Innovation Program fosters and supports collaborative industrial research and development projects with high potential for commercialization between Canada and partner countries. It also stimulates bilateral science and technology networking and matchmaking activities to further new partnerships and accelerate the commercialization of research and development.
Expected Results (French)
Le Programme canadien de l’innovation à l’international favorise et appuie les projets de collaboration en matière de recherche-développement industrielle susceptibles d’être commercialisés entre le Canada et des pays partenaires. Il stimule les activités bilatérales de réseautage et de jumelage en science et technologie afin d’encourager la formation de nouveaux partenariats et d’accélérer la commercialisation de la recherche et du développement.
Federal Riding
Burnaby North--Seymour
Federal Riding (French)
Burnaby-Nord--Seymour
Federal Riding Number
59002
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Canadian International Innovation Program
Program Name (French)
Programme canadien d’innovation à l’international
Program Purpose
The Canadian International Innovation Program fosters and supports collaborative industrial research and development projects with high potential for commercialization between Canada and partner countries. It also stimulates bilateral science and technology networking and matchmaking activities to further new partnerships and accelerate the commercialization of research and development.
Program Purpose (French)
Le Programme canadien de l’innovation à l’international favorise et appuie les projets de collaboration en matière de recherche-développement industrielle susceptibles d’être commercialisés entre le Canada et des pays partenaires. Il stimule les activités bilatérales de réseautage et de jumelage en science et technologie afin d’encourager la formation de nouveaux partenariats et d’accélérer la commercialisation de la recherche et du développement.
Recipient Business Number
826908816
Recipient City
Burnaby|Burnaby
Recipient Country
CA
Recipient Legal Name
iProgen Biotech Inc.
Recipient Postal Code
V5A 4N4
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2019-2020-Q3-939055
